Founded in January 2001, Abnova (Taiwan) Corporation is mainly engaged in the production of proteins and antibodies. The main sources of revenue are the monoclonal antibody, protein and polyclonal antibodies. Main products are exported to Americas, Europe and Asia. In 2004, Abnova began to use IT management experience to get rid of laboratory practices, so that the producing of monoclonal and polyclonal antibodies can be industrialized to increase antibody production. In 2007 Abnova imported shareholders from Oulishi Japan, Dongan investment and Sophia venture. In2008, it began to enter the antibody chip and system development, and expand production of length protein.
Headquarters
9F,No,108,Jhouzih St, Neihu
Taipei City; Taipei City;
Contact Details: Purchase the Abnova (Taiwan) Corporation report to view the information.
Website: http://www.abnova.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service